[{"AccountsPayableCurrent_0_Q1_USD":40484000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":470393000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":136492000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":836346000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":972838000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":968656000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":334000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":4516000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":34578000.0,"DepreciationAmortizationAndAccretionNet_1_Q1_USD":7613000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":9198000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-79235000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":34578000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":539614000.0,"RestrictedCashCurrent_0_Q1_USD":167000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":4045000.0,"AccountsReceivableNet_0_Q1_USD":25970000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":4459000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-177762000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":5289966000.0,"OtherAssetsNoncurrent_0_Q1_USD":19032000.0,"NonoperatingIncomeExpense_1_Q1_USD":28512000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":13302000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-4030000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":6619000.0,"ContractWithCustomerLiability_0_Q1_USD":152829000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":306124000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":99476000.0,"RestrictedInvestmentsNoncurrent_0_Q1_USD":24725000.0,"RestrictedCashNoncurrent_0_Q1_USD":2447000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":-2802000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":53869000.0,"PaymentsToAcquireRestrictedInvestments_1_Q1_USD":9900000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":396409000.0,"PaymentsForProceedsFromTenantAllowance_1_Q1_USD":0.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":660000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q1_USD":-74000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":86043000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":1657000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":221280000.0,"OperatingLeasePayments_1_Q1_USD":9036000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":275782000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":29043000.0,"InvestmentIncomeNet_1_Q1_USD":5480000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":24111000.0,"EquitySecuritiesFvNi_0_Q1_USD":38078000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-631000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":14678000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":340000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":2939000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":23032000.0,"InventoryRawMaterials_0_Q1_USD":30662000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-246161000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":113688000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":53869000.0,"LiabilitiesCurrent_0_Q1_USD":338791000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2279624000.0,"Liabilities_0_Q1_USD":929895000.0,"InventoryNet_0_Q1_USD":68300000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":19958000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":32882000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":575000.0,"NetIncomeLoss_1_Q1_USD":-182221000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-181646000.0,"CostsAndExpenses_1_Q1_USD":309634000.0,"CommonStockValue_0_Q1_USD":1131000.0,"CommonStockSharesOutstanding_0_Q1_shares":113168000.0,"CommonStockSharesIssued_0_Q1_shares":113168000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":467779000.0,"AssetsCurrent_0_Q1_USD":1584773000.0,"Assets_0_Q1_USD":2279624000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":15020000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-32059000.0,"AccountsReceivableNetCurrent_0_Q1_USD":75572000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.62,"InventoryWorkInProcess_0_Q1_USD":33412000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":19617000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":0.0,"InventoryFinishedGoods_0_Q1_USD":4226000.0,"IncreaseDecreaseInInventories_1_Q1_USD":11952000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-14215000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":54221000.0,"ShareBasedCompensation_1_Q1_USD":34578000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":126761000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":169571000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":98698000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OperatingIncomeLoss_1_Q1_USD":-210158000.0,"CommonStockSharesAuthorized_0_Q1_shares":250000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":183221000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":112748000.0,"StockholdersEquity_0_Q1_USD":1349729000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-3909309000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":429814000.0,"ProfitLoss_1_Q1_USD":-182221000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q1_USD":0.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]